Medicine & Life Sciences
Glucagon Receptors
100%
Glucagon
78%
Glucose
43%
Insulin Secretion
28%
Peptides
28%
Insulin
24%
Fats
24%
4-hydroxybenzoic acid 2-bromobenzylidene hydrazide
23%
Obese Mice
22%
N-(3-(2-amino-4a,5,7,7a-tetrahydro-4H-furo(3,4-d)(1,3)thiazin-7a-yl)-4-fluorophenyl)-5-fluoropicolinamide
21%
Homeostasis
19%
wedelolactone
17%
Blood Glucose
14%
Type 2 Diabetes Mellitus
14%
Neuropeptide Y Receptors
13%
Muscarinic M3 Receptors
13%
Gastric Inhibitory Polypeptide
13%
Phenotype
12%
Glucagon-Like Peptide-1 Receptor
11%
Cannabinoid Receptors
11%
Insulin Resistance
11%
Endocannabinoids
11%
gastric inhibitory polypeptide receptor
10%
Alzheimer disease type 2
10%
Endoplasmic Reticulum Stress
10%
Cholinergic Receptors
10%
Hypoglycemic Agents
9%
Hyperglycemia
9%
Somatostatin
9%
Rodentia
9%
Zebrafish
9%
Biological Products
9%
In Vitro Techniques
7%
Glucose Tolerance Test
7%
Molecular Weight
7%
Insulin Receptor
7%
Pathology
6%
Therapeutics
6%
Inflammation
6%
Liver
6%
Amyloid beta-Protein Precursor
6%
Diet
6%
Dipeptidyl Peptidase 4
6%
Alzheimer Disease
6%
Guidelines
5%
Hormones
5%
Messenger RNA
5%
Brain
5%
Chemical Compounds
Glucagon
37%
Insulin Derivative
24%
Glucagon Receptor Antagonist
20%
Glucose
18%
Fat
18%
Wedelolactone
17%
Glucagon-Like Peptide 1
14%
Ablation
11%
Metabolic
10%
Insulinotropic
10%
Antagonist
8%
Occurrence in Nature
7%
Hyperglycemic
7%
Protective Agent
6%